Neurociencia del consumo y dependencia de sustancias psicoactivas

NEUROCIENCIA DEL CONSUMO Y DEPENDENCIA DE SUSTANCIAS PSICOACTIVAS
Delgado PL y colab. (1990) Serotonin function and the mechanism of antidepressant
action: reversal of antidepressant-induced remission by rapid depletion
of plasma tryptophan. Archives of General Psychiatry, 47:411–418.
Delgado PL y colab. (1991) Rapid serotonin depletion as a provocative challenge
test for patients with major depression: relevance to antidepressant action and
the neurobiology of depression. Psychopharmacology Bulletin, 27:321–330.
Delgado PL y colab. (1993) Monoamines and the mechanism of antidepressant
action: effects of catecholamine depletion on mood of patients treated with antidepressants.
Psychopharmacology Bulletin, 29:389–396.
Delgado PL y colab. (1994) Serotonin and the neurobiology of depression:
effects of tryptophan depletion in drug-free depressed patients. Archives of
General Psychiatry, 51:865–874.
de Montigny C, Aghajanian GK (1978) Tricyclic antidepressants: long-term
treatment increases responsivity of rat forebrain neurons to serotonin. Science,
202:1303–1306.
Desai NG y colab. (1984) Treatment of negative schizophrenia with d-amphetamine.
American Journal of Psychiatry, 141:723–724.
Di Chiara G y colab. (1999) Drug addiction as a disorder of associative learning:
role of nucleus accumbens shell/extended amygdala dopamine. Annals of the
New York Acadamy of Sciences, 877:461–485.
Diwan A y colab. (1998) Differential prevalence of cigarette smoking in patients
with schizophrenic vs mood disorders. Schizophrenia Research, 33:113–118.
Dixon L (1999) Dual diagnosis of substance abuse in schizophrenia: prevalence
and impact outcomes. Schizophrenia Research, 35 Suppl: S93–S100.
Dixon L y colab. (1990) Acute effects of drug abuse in schizophrenic patients:
clinical observations and patients’ self-reports. Schizophrenia Bulletin, 16:69–79.
Dixon L y colab. (1991) Drug abuse in schizophrenic patients: clinical correlates
and reasons for use. American Journal of Psychiatry, 148:224–230.
Duncan GE, Sheitman BB, Lieberman JA (1999) An integrated view of pathophysiological
models of schizophrenia. Brain Research Reviews, 29:250–264.
Edwards G (1990) Withdrawal symptoms and alcohol dependence: fruitful mysteries.
British Journal of Addiction, 85:447–461.
Ellenbogen MA y colab. (1996) Mood response to acute tryptophan depletion
in healthy volunteers: sex differences and temporal stability.
Neuropsychopharmacology, 15:465–474.
Ellenbroek BA, Cools AR (2000) Animal models for the negative symptoms of
schizophrenia. Behavioural Pharmacology, 11:223–233.
Escamilla MA y colab. (2002) Comorbidity of bipolar disorder and substance
abuse in Costa Rica: pedigree- and population-based studies. Journal of Affective
Disorders, 71:71-83.
Fatemi SH, Earle JA, McMenomy T (2000) Reduction in Reelin immunoreactivity
in hippocampus of subjects with schizophrenia, bipolar disorder and major
depression. Molecular Psychiatry, 5:654–663.
Feighner JP y colab. (1984) A double-blind study of bupropion and placebo in
194